ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) FCF Yield % : -472.84 (As of May. 17, 2024)

View and export this data going back to 2018. Start your Free Trial

What is ASLAN Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, ASLAN Pharmaceuticals's Trailing 12-Month Free Cash Flow is $-46.65 Mil, and Market Cap is $9.87 Mil. Therefore, ASLAN Pharmaceuticals's FCF Yield % for today is -472.84%.

The historical rank and industry rank for ASLAN Pharmaceuticals's FCF Yield % or its related term are showing as below:

ASLN' s FCF Yield % Range Over the Past 10 Years
Min: -515.41 Med: -20.36 Max: -7.9
Current: -472.84

During the past 10 years, the highest FCF Yield % of ASLAN Pharmaceuticals was -7.90%. The lowest was -515.41%. And the median was -20.36%.

ASLN's FCF Yield % is ranked worse than
96.4% of 1557 companies
in the Biotechnology industry
Industry Median: -14.1 vs ASLN: -472.84

ASLAN Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

ASLAN Pharmaceuticals FCF Yield % Historical Data

The historical data trend for ASLAN Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASLAN Pharmaceuticals FCF Yield % Chart

ASLAN Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-33.46

-19.62

-43.58

-153.07

-507.76

ASLAN Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ASLAN Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, ASLAN Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASLAN Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASLAN Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where ASLAN Pharmaceuticals's FCF Yield % falls into.

ASLAN Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

ASLAN Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-46.65	/	9.18744591
	=	-507.76%

ASLAN Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	13.92000736
	=	0.00%

ASLAN Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

ASLAN Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of ASLAN Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASLAN Pharmaceuticals Ltd (NAS:ASLN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Temasek Avenue, Level 18, Centennial Tower, Singapore, SGP, 039190

Website

https://www.aslanpharma.com

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.